MLH1 and neoplasm: Future plans including the use of additional antibodies, for example, against p53, MUC-1, the mismatch repair proteins hMLH1 and hMSH2, or cell cycle-specific proteins, may help to define the circulating cells unequivocally as tumour cells even without the need to do FISH.